reported SGLT2 expression in epicardial adipose tissue, increased in vitro glucose uptake and GLUT4, reduced secretion of proinflammatory chemokines, and improved differentiation of EAT cells with dapagliflozin in EAT of patients undergoing open heart surgery (30% T2D, and 50% with CAD) [37]. The gene discussed is SLC2A4; the disease is type 2 diabetes mellitus.